CVR 10024951Public limited company (A/S)Fremstilling af farmaceutiske råvarer (244100)HvidovreFounded 21 Mar 2000
CVR registers no owner holding 5% or more.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about BIOCUR A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexCVR registers no owner holding 5% or more.
Jens Piilgaard Nielsenuntil 1 Sep 2006
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report, the business model and the revenue model a calibrated decision model reading the report's text and the purpose clause, not registered by the company. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
21 Mar 2000 to 14 Nov 2026.
Not available in the CVR filing: the annual reports carry no machine-readable figures.
Annual report 2005
1 Jan 2005 to 31 Dec 2005, published 9 Jun 2006
Annual report 2004
1 Jan 2004 to 31 Dec 2004, published 1 Jun 2005
Annual report 2003
1 Jan 2003 to 31 Dec 2003, published 1 Jun 2004
Annual report 2002
1 Jan 2002 to 31 Dec 2002, published 7 May 2003
Annual report 2001
1 Jan 2001 to 31 Dec 2001, published 18 Apr 2002
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For BIOCUR A/S, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
Merger (fusion), as the ceasing company (ophørende selskab)
From CVR, read 14 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 14 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
12 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Selskabet opløst efter fusion med CVR-NR. 27744532 SANDOZ A/S.
Erhvervs- og Selskabsstyrelsen har modtaget
fusionsplan i henhold til aktieselskabslovens § 134 a
for fusion mellem
CVR-NR. 27744532 SANDOZ A/S. der tillige driver virksomhed under navnene DURASCAN A/S (SANDOZ A/S), DURASCAN MEDICAL PRODUCTS A/S (SANDOZ A/S).
CVR-NR. 25538846 1A FARMA A/S.
CVR-NR. 10024951 BIOCUR A/S.
Bestyrelse:
Tiltrådt som formand:
Ken Rasmussen, den 05.05.2006, Fratrådt som formand, men forbliver i bestyrelsen: Hari Sven Venkita Ayer Krishnan, den 05.05.2006.
Udtrådt af bestyrelsen:
Andreas Strüngmann, den 05.05.2006.
Indtrådt i bestyrelsen:
Eric Gorka, den 05.05.2006.
Bestyrelse:
Udtrådt af bestyrelsen:
Michael Steen Jensen, den 02.11.2005, Allan Dam Nielsen, den 02.11.2005.
Indtrådt i bestyrelsen:
Hari Sven Venkita Ayer Krishnan (formand), den 02.11.2005, Ken Rasmussen, den 02.11.2005, Dr. Andreas Strüngmann, den 02.11.2005.
Direktion:
Udtrådt af direktionen:
Karsten Høilund Skafte, den 30.09.2005.
Indtrådt i direktionen:
Jens Piilgaard Nielsen, den 30.09.2005.
Bestyrelse:
Udtrådt af bestyrelsen:
Werner Leppla, den 17.11.2004, Andreas Strüngmann, den 17.11.2004.
Indtrådt i bestyrelsen:
Allan Dam Nielsen, den 17.11.2004.
Revision:
Vedtægter ændret:
25.05.2004.
Ny adresse:
c/o Hexal A/S, Kanalholmen 8-12, 2650 Hvidovre.
Ny kommune:
Hvidovre.
Revision:
Udtrådt af revisionen:
BDO SCANREVISION STATSAUTORISERET REVISIONSAKTIESELSKAB, den 23.11.2000.
Indtrådt i revisionen:
CVR-NR. 39746115 KPMG DANMARK STATSAUTORISERET REVISIONSAKTIESELSKAB, Borups Alle 177, postboks 250, 2000 Frederiksberg, den 23.11.2000.
Bestyrelse:
Tiltrådt som formand:
Werner Leppla, den 21.03.2000.
Indtrådt i bestyrelsen:
Advokat Michael Steen Jensen, den 21.03.2000, Karsten Høilund Skafte, den 21.03.2000.
Direktion:
Udtrådt af direktionen:
Søren Bols Pedersen, den 21.03.2000.
Indtrådt i direktionen:
Karsten Høilund Skafte, den 21.03.2000.
Stiftelsesdato:
21.03.2000.
Seneste vedtægtsdato:
21.03.2000.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
kontant kr. 500.000,00 til kurs 100,00.
Stifter:
CVR-NR. 62970715 A/S GEA FARMACEUTISK FABRIK, Holger Danskes Vej 89, 2000 Frederiksberg, den 21.03.2000.
Bestyrelse:
Werner Leppla, den 21.03.2000, Udviklingsdirektør Søren Bols Pedersen, den 21.03.2000, Dr Andreas Strüngmann, den 21.03.2000.
Direktion:
Udviklingsdirektør Søren Bols Pedersen, den 21.03.2000.
Selskabet tegnes af to bestyrelsesmedlemmr i forening eller af et medlem af bestyrelsen i forening med en direktør.
Revision:
BDO SCANREVISION STATSAUTORISERET REVISIONSAKTIESELSKAB, Strandgade 12, 1401 København K, den 21.03.2000.
Første regnskabsår:
21.03.2000 - 31.12.2000.
Regnskabsår:
01.01 - 31.12.
1 registered in CVR.
P-number 1007484557Kanalholmen 8, 2650 Hvidovre